Parents hoping to vaccinate their young children against COVID-19 will need to be patient, Dr. Anthony Fauci cautioned Wednesday.
The director of the National Institute of Allergy and Infectious Diseases said while he expects the vaccine regimen for children under 5 will be three doses, he couldn’t provide a timeline on when the federal government would approve emergency use of those vaccines.
“I don’t think we can predict when we will see an [emergency use authorization] with that because the company is still putting the data before the FDA,” Fauci said, referring to the Food and Drug Administration.
Fauci said the pace is an indication that the system works, since the FDA is being “scrupulous” in making sure “that when these vaccines become available for children at those ages that we can be certain that they will be safe and they will be effective.”
Pfizer and BioNTech have been testing a vaccine for young children for months, but Fauci said Wednesday that the original data of trial participants between 2 and 4 didn’t reach the level of protection that experts were looking for, even though doses for children between six months old and 2 “worked well.”
The FDA approved COVID-19 vaccines for children 5 to 11 in October under an emergency use authorization, but parents of children younger than that have been stuck in limbo ever since.
Fauci said Wednesday that he wasn’t involved in the FDA’s approval process or privy to the data for the ongoing process.
“Bottom line – I can’t give you a timetable on that,” he said. “We’ll just have to wait and see.”
Jennifer Shutt
Senior reporter, Washington bureau
Jennifer covers the nation’s capital as a senior reporter for States Newsroom. Her coverage areas include congressional policy, politics and legal challenges with a focus on health care, unemployment, housing and aid to families.Before joining States Newsroom, Jennifer covered Congress for CQ Roll Call for more than six years. As a budget and appropriations reporter, she tracked the annual federal funding process as well as disaster aid and COVID-19 spending. Jennifer is originally from northern Pennsylvania and holds degrees in journalism and political science from Penn State University. After graduating, she began her journalism career as a reporter for The Daily Times in Maryland where she covered local and state government. Jennifer then moved to Washington, D.C. to work as a web producer at Politico.
Related Articles
A bill that got a boost of momentum right before the end of the 2024 legislative session tries to keep lower- priced prescription drugs accessible to lower income Marylanders.
The advisory is primarily for poultry and livestock owners, and emphasizes that current risk for the general public is low.
‘The legislative work is not dissimilar from the patient care and clinical work I do. It’s about helping people…you’re interacting with others, you’re really trying to solve their problems,’ Lam said.
Creative Commons Attribution